RE: Effects of testosterone replacement on response to sildenafil citrate

Annals of Internal Medicine

Volumn 158, Issue 7, 2013, Pages 569-

  Seftel, Allen D ^a   Hackett, Geoffrey ^b  

^a Cooper University Hospital ^*  (United States)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TESTOSTERONE; ANDROGEN; PIPERAZINE DERIVATIVE; SULFONE;

BODY MASS; DRUG DOSE TITRATION; DRUG EFFICACY; ERECTILE DYSFUNCTION; HORMONE SUBSTITUTION; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LETTER; MEDICAL DECISION MAKING; PRIORITY JOURNAL; TREATMENT OUTCOME; MALE; NOTE;

ANDROGENS; ERECTILE DYSFUNCTION; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; SULFONES; TESTOSTERONE;

EID: 84875706628     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-7-201304020-00017     Document Type: Letter

References (4)

1. Spitzer M, Basaria S, Travison TG, Davda MN, Paley A, Cohen B, et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunc-tion: a parallel, randomized trial. Ann Intern Med. 2012;157:681-91.
2. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evalua-tion of the erectile function domain of the International Index of Erectile Function. Urology. 1999;54:346-51.
3. Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011;60:1010-6.
4. Buvat J, Hatzichristou D, Maggi M, Farmer I, Martínez-Jabaloyas JM, Miller PJ, et al. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration com-pared with continued 50-mg dose treatment in men with erectile dysfunction. BJU Int. 2008;102:1645-50.